Exo® Announces Samsung Medison Strategic Collaboration and Welcomes Omar Ishrak to its Board
Summary
The partnership includes a strategic equity investment by Samsung, aimed at accelerating the development of next-generation ultrasound platforms. Kyu Tae Yoo, CEO of Samsung Medison, welcomed the partnership with Exo.Our collaboration with Exo marks a significant step toward advancing transformation in ultrasound imaging. We are committed to delivering innovation that improves diagnostic capabilities and enhances the clinical experience for patients and practitioners alike.Omar Ishrak Chairman of Qubit Health Capital, former Chairman and CEO of Medtronic, and prior CEO of GE Healthcare Systems said, Exos technology has the potential to significantly improve diagnostic precision and accessibility. The company is focused on creating imaging systems that are compact, high-performance, with potential applications across a variety of care settings. This collaboration is expected to lay the foundation for future innovation in real-time imaging.The partnership reflects a shared vision between Exo and Samsung Medison to drive global advancement in ultrasound through large-scale innovation and strategic co-development.About Exo ImagingExo is redefining medical imaging with its advanced ultrasound platform, combining novel silicon-based hardware, tightly coupled AI, and easy-to-use collaboration software.